A previous study showed that inhibition of fatty acid synthase (FASN) blocks HIF-1α/VEGF-A signaling in response to hypoxia, and suppresses neovascularization in glioma by upregulating VEGF165b37. Here, FASN is linked to central nervous system cancer.